ZORMID 20MG/ML EYE DROPS, SOLUTION

Pajjiż: Ċipru

Lingwa: Grieg

Sors: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Ingredjent attiv:

DORZOLAMIDE HYDROCHLORIDE

Disponibbli minn:

DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629

Kodiċi ATC:

S01EC03

INN (Isem Internazzjonali):

DORZOLAMIDE

Dożaġġ:

20MG/ML

Għamla farmaċewtika:

EYE DROPS, SOLUTION

Kompożizzjoni:

DORZOLAMIDE HYDROCHLORIDE (8000002380) 22,26MG

Rotta amministrattiva:

OCULAR USE

Tip ta 'preskrizzjoni:

Εθνική Διαδικασία

Żona terapewtika:

DORZOLAMIDE

Sommarju tal-prodott:

Νομικό καθεστώς: Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 1 BOTTLE X 5ML (330024001) 5 MILLILITRE - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 3 BOTTLES X 5ML (330024002) 15 MILLILITRE - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 6 BOTTLES X 5ML (330024003) 30 MILLILITRE - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται

Fuljett ta 'informazzjoni

COMPARATIVE TABLE ENGLISH VS GREEK PIL
PACKAGE LEAFLET: INFORMATION FOR THE USER
ZORMID 20 MG/ML EYE DROPS, SOLUTION
dorzolamide
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. See
section 4.
WHAT IS IN THIS LEAFLET
1.
What Zormid is and what it is used for
2.
What you need to know before you use Zormid
3.
How to use Zormid
4.
Possible side effects
5.
How to store Zormid
6.
Contents of the pack and other information
1.
WHAT ZORMID IS AND WHAT IT IS USED FOR
Zormid contains the active substance dorzolamide which belongs to a
group
of medicines called "carbonic anhydrase inhibitors".
This medicine is prescribed to lower raised pressure in the eye and to
treat
ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ: ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ
ΤΟΝ ΧΡΉΣΤΗ
ZORMID 20 MG/ML ΟΦΘΑΛΜΙΚΈΣ ΣΤΑΓΌΝΕΣ, ΔΙΆΛΥΜΑ
δορζολαμίδη
ΔΙΑΒΆΣΤΕ
ΠΡΟΣΕΚΤΙΚΆ ΟΛΌΚΛΗΡΟ
ΤΟ ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ
ΠΡΙΝ
ΑΡΧΊΣΕΤΕ ΝΑ ΧΡΗΣΙΜΟΠΟΙΕΊΤΕ ΑΥΤΌ ΤΟ
ΦΆΡΜΑΚΟ ΔΙΌΤΙ ΠΕΡΙΛΑΜΒΆΝΕΙ
ΣΗΜΑΝΤΙΚΈΣ ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΣΑΣ.

Φυλάξτε
αυτό το φύλλο οδηγιών
χρήσης. Ίσως χρειαστεί
να το
διαβάσετε ξανά.

Εάν
έχετε
περαιτέρω
απορίες,
ρωτήστε
τοv
γιατρό
ή
τοv
φαρμακοποιό σας.

Η συνταγή για αυτό το φάρμακο
χορηγήθηκε αποκλειστικά για σας.
∆εν πρέπει να δώσετε

Karatteristiċi tal-prodott

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
ZORMID 20 mg/ml Eye drops, solution
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains 22.26 mg of dorzolamide hydrochloride corresponding
to 20 mg of
dorzolamide.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Eye drops, solution.
Clear, colourless, slightly viscous, aqueous solution.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
ZORMID is indicated:

as adjunctive therapy to beta-blockers,

as monotherapy in patients unresponsive to beta-blockers or in whom
beta-blockers are
contraindicated,
in the treatment of elevated intra-ocular pressure in:

ocular hypertension,

open-angle glaucoma,

pseudo-exfoliative glaucoma.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
When used as monotherapy, the dose is one drop of dorzolamide in the
conjunctival sac of the
affected eye(s), three times daily.
When used as adjunctive therapy with an ophthalmic beta-blocker, the
dose is one drop of
dorzolamide in the conjunctival sac of the affected eye(s), two times
daily.
When substituting dorzolamide for another ophthalmic anti-glaucoma
agent, discontinue the
other agent after proper dosing on one day, and start dorzolamide on
the next day.
If more than one topical ophthalmic drug is being used, the drugs
should be administered at
least ten minutes apart.
Patients should be instructed to wash their hands before use and avoid
allowing the tip of the
container to come into contact with the eye or surrounding structures.
Patients should also be instructed that ocular solutions, if handled
improperly, can become
contaminated by common bacteria known to cause ocular infections.
Serious damage to the
eye and subsequent loss of vision may result from using contaminated
solutions.
Patients should be informed of the correct handling of the bottles.
_Usage instructions:_
It is recommended that you wash your hands before putting in your eye
drops.
It may be easier to apply your eye drops in front of a mirror.
1.
Before usin